PowderMed developed vaccines for the treatment of chronic infectious diseases and cancer. The company used DNA coated gold particles delivered by a needle-free injection device to stimulate a powerful and specific T cell immune response. PowderMed was spun-out of Chiron Corporation. The company was acquired by Pfizer in October 2006.

Location Oxford, UK